Objectives: Limited data exist regarding the role of agr dysfunction in reducing susceptibility to vancomycin in methicillin-susceptible Staphylococcus aureus (MSSA). This study investigated the clinical and molecular epidemiology of MSSA causing bacteraemia, with emphasis on the reduced susceptibility to vancomycin (RSV) phenotype (MIC ≥1.5 mg/L) and its relationship with agr dysfunction.
Introduction
Staphylococcus aureus is one of the most frequently recovered microorganisms in cases of bloodstream infection and S. aureus bacteraemia (SAB) is associated with high morbidity and mortality. 1 Over the past 20 years, the incidence of bacteraemia associated with methicillin-resistant S. aureus (MRSA) has increased. 2 Although vancomycin is first-line therapy for bacteraemic patients, there are increasing reports of treatment failure despite MICs within the susceptible range. 3, 4 A recent meta-analysis suggested that patients with MRSA bacteraemia and reduced susceptibility to vancomycin (RSV) (MIC ≥1.5 mg/L) had a higher likelihood of mortality and treatment failure. 5 Although more clinical research has focused on MRSA bacteraemia, mortality rates for methicillin-susceptible S. aureus (MSSA) have been shown to vary from 12% to 32%. 5 We previously reported the relationship between the RSV phenotype and the development of complicated catheter-related bacteraemia caused by MSSA. 6 Additionally, a recent prospective multinational study showed an association between higher vancomycin MIC and increased mortality in SAB patients infected with either MRSA or MSSA. 7 The accessory gene regulator (agr) is a quorum-sensing operon that up-regulates the production of secreted virulence factors, including haemolysins and exotoxins, and down-regulates the production of cell-associated virulence factors. 8 -10 agr regulates the synthesis of RNAIII, the effector of target gene regulation. RNAIII also encodes d-haemolysin, the production of which can therefore be used as a semi-quantitative surrogate for agr function. 11, 12 agr dysfunction has been associated with attenuation of vancomycin bactericidal activity, 13 as well as the vancomycin-intermediate S. aureus (VISA) and heteroresistant VISA (h-VISA) phenotypes. 14 Additionally, a recent study has demonstrated that agr dysfunction in SAB isolates was associated with excessive mortality among severely ill patients. 15 Nevertheless, limited data exist as to whether agr dysfunction plays a role in the RSV phenotype in MSSA. The aim of the present study was to investigate the clinical and molecular epidemiology of MSSA isolates causing bacteraemia, with an emphasis on characterization of the RSV phenotype and its relationship with agr. Finally, we determined the bactericidal activity of oxacillin against RSV isolates of MSSA.
Methods

Study design and clinical characteristics of patients
We conducted a retrospective study of all patients who had an episode of SAB between January 2010 and January 2011 at the University Hospital 12 de Octubre in Madrid (Spain), a 1300 bed tertiary-care university medical centre. Only the first episode of bacteraemia for each patient was considered. Unique (non-duplicated) clinical isolates from SAB patients were collected during the study period. MRSA bacteraemia cases were excluded from the study to focus on MSSA.
Microbiology and susceptibility testing
All blood samples were inoculated and processed in an automated bloodculture testing system (BACTEC 9240, Becton Dickinson Microbiological Systems, Sparks, MD, USA). Identification and susceptibility testing were performed using conventional methods and the WIDER System (Soria Melguizo, Madrid, Spain) according to CLSI criteria. 16 All clinical MSSA isolates were analysed by the Etest method to determine vancomycin, daptomycin, oxacillin and linezolid MICs. In addition, the Etest macromethod was performed to screen for h-VISA. 17 All strains were stored at 2808C after susceptibility testing.
In order to conduct this study, we classified all clinical MSSA isolates into two groups: vancomycin MIC ,1.5 mg/L and vancomycin MIC ≥1.5 mg/L (RSV). Forty of these strains were randomly selected to perform time-kill experiments and RNAIII quantitative RT-PCR (see below).
Time -kill experiments
Selective time-kill experiments were performed in duplicate for vancomycin and oxacillin against MSSA strains belonging to both classes of vancomycin MIC (,1.5 or ≥1.5 mg/L). We determined the reduction in colony counts after 0, 6, 24, 48 and 72 h in Mueller-Hinton broth containing 16 mg/L vancomycin 18 using an initial bacterial inoculum of 10 7 -10 8 cfu/mL. 19 Similarly, the effect of 20 mg/L oxacillin was determined after 0, 6, 8, 24 and 48 h with an initial inoculum of 10 6 cfu/mL. 20, 21 A bactericidal effect was defined as a reduction of ≥3 log 10 cfu/mL compared with the initial inoculum.
agr phenotyping studies and RNAIII quantitative RT-PCR
The functionality of the agr operon was measured by d-haemolysin production, as determined by streaking each SAB isolate adjacent to S. aureus strain RN4220 on a trypticase soy agar plate supplemented with 5% sheep blood and incubating overnight at 378C. An enhanced area of haemolysis at the intersection of the b-haemolytic RN4220 strain with the SAB isolate was taken as indicative of the production of d-haemolysin and, therefore, a functional agr locus. 12, 22 agr dysfunction was defined as the complete absence of d-haemolysis.
Quantitative RT-PCR was performed on selected MSSA isolates. Overnight cultures were subcultured in a 1 : 100 dilution of fresh trypticase soy broth. Cell growth was monitored by spectrometric readings at 600 nm, up to an optical density of 1.0. RNAwas isolated using the High Pure RNA Isolation Kit (Roche) and transcribed into cDNA using a Transcriptor First Strand cDNA Synthesis Kit (Roche). Quantitative real-time PCR was carried out using a LightCycler w 2.0 (Roche Applied) with LightCycler w FastStart DNA Master Plus SYBR Green I (Roche Applied Science). Expression levels of the housekeeping gene gyrB were used to normalize differences in transcript quantification. 10 Previously described primers were used to amplify RNAIII and gyrB transcripts. 23 Relative levels of RNAIII expression were calculated based on the difference in the cycle thresholds (DCt¼gyrB Ct2 RNAIII Ct) for all selected samples. 22 PCR experiments were performed using three biological replicates, each tested in triplicate.
Molecular typing and microarray-based genotyping
Molecular characterization of all MSSA isolates was performed by PFGE with SmaI digestion according to previously described methods.
24,25 DNA microarrays based on the ArrayTube platform were performed for all MSSA isolates according to the manufacturer's instructions (Clondiag, Jena, Germany). The array used in this study covers 334 target sequences comprising allelic variants of 185 distinct genes that include species markers, antimicrobial resistance genes, exotoxins and genes encoding microbial surface components recognizing adhesive matrix molecules of the host, as well as capsule, clonal complex (CC) and agr group markers I, II, III and IV. 26 Multilocus sequence typing (MLST) was performed as described previously 27 in all isolates that belonged to a major CC. Sequence types (STs) were assigned using the MLST web site (www.mlst.net).
Statistical analyses
Simple descriptive statistics were used to describe patient characteristics and the genetic profile of the clinical isolates. Categorical variables were analysed and the two groups (vancomycin MIC ,1.5 mg/L and RSV isolates) were compared using the x 2 test or Fisher's exact test for association. Continuous variables were analysed by Student's t-test or the Mann-Whitney U-test. Significance was defined as P, 0.05. Data were stored and analysed using SPSS software version 15.0 (SPSS, Chicago, IL, USA).
Results
General characteristics of SAB episodes
Between January 2010 and January 2011, we collected a total of 112 SAB isolates: 84 MSSA and 28 MRSA. The characteristics of the patients with MSSA bacteraemia are shown in Table 1 . Of the 84 MSSA, 29 (34.5%) were susceptible to vancomycin (MIC ,1.5 mg/L) and 55 (65.5%) exhibited RSV (vancomycin MIC ≥1.5 mg/L). There were no significant differences between the two groups in terms of demographic characteristics, association of infection with the healthcare system, source of bacteraemia and previous antibiotic exposure and treatment ( Table 1 ). The in-hospital mortality rate was higher in the group with the RSV phenotype (45.5% versus 24.1%, P ¼ 0.057).
MIC distribution and molecular characterization of MSSA
We investigated the MIC distribution for oxacillin, daptomycin and linezolid and observed no differences in MICs between the two groups. We did not find any isolates that exhibited the VISA or h-VISA phenotypes among the MSSA isolates.
PFGE analysis showed a high clonal diversity. The most common CCwas CC30 (ST30) with 16 isolates (19%), followed by CC5 (ST125) with 14 (16.7%), CC45 (ST45) with 11 (13.1%), CC15 (ST15) with 8 (9.5%) and CC25 (ST25) with 5 (6.0%). The remaining 30 isolates (35.7%) were from 17 different CCs. CC5 (ST125) was the most Viedma et al.
common in the MSSA RSV group, representing 22% of isolates, followed by CC30 (16%) and CC45 (13%) ( Table 2 ). Among CCs associated with hospital onset of infection, CC30 (14, 21.5%) was the most common, followed by CC5 (12, 18.5%), CC15 (8, 12 .3%) and CC45 (8, 12 .3%). These CCs were also found to be circulating in the community: CC5 (1, 5.3%), CC25 (2, 10.5%), CC30 (2, 10.5%) and CC45 (2, 10.5%).
Overall, agr type I was the most prevalent among MSSA isolates (40.5%), followed by agr type II (33.3%). We found a correlation between isolates with the RSV phenotype and agr II genotype (P ¼ 0.023) ( Table 2 ). We also observed that the lukD gene was more frequently found among RSV isolates than among vancomycin-susceptible isolates (60.0% versus 34.5%, P ¼ 0.026) ( Table 2) .
Relationship between RNAIII expression and agr polymorphism with RSV MSSA Phenotypically, we found that 37.0% of MSSA isolates exhibited agr dysfunction (d-haemolysis negative): 48.3% among vancomycin MIC ,1.5 mg/L MSSA and 30.9% among RSV isolates (P ¼ 0.119) ( Table 2 ). There were no statistically significant differences in demographic characteristics between patients infected with isolates exhibiting functional or dysfunctional agr. The rates of mortality within 30 days were also similar between the groups with functional and dysfunctional agr [24.5% (13/53) versus 12.9% (4/31), P ¼ 0.159].
Once the random selection had taken place, we found 18 vancomycin-susceptible MSSA isolates and 22 RSV isolates, with 7 (38.9%) and 6 (27.3%) that were phenotypically negative for d-haemolysis, respectively. The patients included in the two groups were similar with regard to age, sex, onset of infection and source of bacteraemia.
First, we investigated whether the phenotypic assessment of d-haemolysin production was concordant with the results from RNAIII expression analysis. There were no significant differences in the average DCt between the groups of isolates that did or did not exhibit d-haemolysis (3.29+3.31 versus 1.53+1.74, P ¼ 0.260). We then analysed RNAIII expression in vancomycinsusceptible and RSV isolates of MSSA (Table 3) . RNAIII quantification revealed a higher average expression in those isolates that were vancomycin MIC ,1.5 mg/L (4.05+3.29 versus 1.5+2.11, P ¼ 0.005), implying a higher degree of agr dysfunction among RSV MSSA isolates (Figure 1) .
Among the 40 MSSA selected for genotyping, agr type II was the most common among RSV isolates (72.7% versus 27.8%, P ¼ 0.005), whereas agr type I was more common in vancomycin MIC ,1.5 mg/L isolates (44.4% versus 13.6%, P ¼ 0.034) (Table S1 , available as Supplementary data at JAC Online). The average DCt for RNAIII expression in agr II and non-agr II isolates was 1.83+2.20 and 3.7+3.47, respectively (P ¼ 0.046), indicating 
Bactericidal activity of oxacillin against RSV MSSA isolates
To investigate whether the bactericidal activity of vancomycin and oxacillin could be affected by the RSV phenotype, we studied the bactericidal activity of these two antimicrobials against the same 40 randomly selected MSSA isolates. The mean of oxacillin bactericidal activity at 24 h was 3.44+1.13 log cfu/mL and the mean of vancomycin bactericidal activity at 48 h was 5.22+2.0 log cfu/ mL (Table 3) . When we analysed the oxacillin bactericidal activity according to the vancomycin MIC, we found that the mean values were 3.24+0.85 for vancomycin-susceptible isolates and 3.63+1.25 for RSV isolates (P¼ 0.264). The mean values of vancomycin bactericidal activity against vancomycin-susceptible isolates and RSV isolates were 5.64+2.20 log cfu/mL and 4.81+1.75, respectively (P ¼ 0.197) ( Table 3) .
Discussion
This study describes the epidemiology of the RSV phenotype in MSSA isolates at a tertiary healthcare facility in Madrid (Spain) and the influence of agr dysfunction on this population. The majority of cases of RSV S. aureus reported in the literature have involved isolates of MRSA, with only a few well-described cases involving RSV in MSSA or h-VISA. 28 -30 Our study revealed that 65.5% of MSSA isolates exhibited the RSV phenotype. Other studies have also reported a high proportion (.70%) of MSSA and MRSA bloodstream isolates with the RSV phenotype. 7, 15 We intended to investigate the possible relationship between the RSV phenotype and agr dysfunction. Previously, agr dysfunction has mostly been studied in MRSA strains. However, our investigation demonstrated a statistically significant correlation between Table 3 . agr dysfunction in and bactericidal activity of oxacillin and vancomycin against selected MSSA bacteraemic isolates In many studies, agr functionality is tested using a phenotypic assay based on d-haemolysin production; 15, 31 although, in the present investigation, we did not find a good correlation between the results of the d-haemolysin assay and the quantification of RNAIII gene expression. It has been reported that phenol-soluble modulins (PSMs) other than d-haemolysin (also known as PSM-g) also possess synergistic haemolytic activity. 32 Whereas the phenotypic assay is easy to conduct, interpretation of the results is subjective and results may vary both intra-and interlaboratory, especially for those isolates with weak haemolytic activity. 33 Our results suggest that the synergistic haemolytic reaction is not an accurate marker of agr functionality.
In order to gain insights into the genetic makeup of RSV MSSA isolates from bacteraemic patients, we first investigated the clonality of these isolates by PFGE analysis. We observed a high clonal diversity among RSV MSSA, similar to that evident among vancomycin-susceptible isolates. Notably, clones exhibiting the RSV phenotype were found to be circulating in the community as well as in the hospital setting.
We also studied the antibiotic resistance and virulence determinants of MSSA isolates using an array hybridization assay. Although in general the genetic content of isolates with the RSV and normal phenotypes were similar, we observed a few differences. The lukD gene was more frequently present in RSV isolates and cna in the vancomycin ,1.5 mg/L group. Although the role of these genes in determining this phenotype is unclear, other studies have linked certain genes with the h-VISA phenotype 34 and with MRSA or MSSA isolates causing infective endocarditis and osteomyelitis. 35 -38 Further studies are therefore needed to determine the causative role of this or other genes in the RSV phenotype and the virulence of particular isolates.
The clinical importance of bactericidal therapy in the treatment of most infections remains controversial. Recently published in vitro data suggest that isolates of S. aureus with high vancomycin MICs could have reduced susceptibility to cloxacillin. 31 We first investigated whether the subtle differences in the vancomycin MIC between MSSA isolates with RSV and normal phenotypes could have a correlation with oxacillin bactericidal activity. Although poor clinical response to oxacillin treatment in patients with RSV MSSA bacteraemia has recently been reported, 7 we found that the in vitro bactericidal activities of vancomycin and oxacillin were similar against both the RSV and the vancomycin-susceptible groups of isolates, suggesting that there is no correlation between the bactericidal activity of this agent and the RSV phenotype. Viedma et al.
Our study has a number of limitations. First, we only evaluated RNAIII expression at a single timepoint, whereas agr activation is time-and population-density dependent. 8 Evaluation of RNAIII expression at multiple timepoints would better define the RNAIII transcription profiles and agr functionalities; however, such an approach is not practical for screening. 8, 33 Moreover, the fact that MSSA isolates with different agr types (I, II, III and IV) were included in the study makes it difficult to define what the meaning of dysfunctional expression was in the isolates studied. On the other hand, although several studies have linked RSV with an increase of mortality, 12 we found no statistically significant relationship between the RSV phenotype in MSSA isolates and mortality rates, although we observed a trend towards higher mortality in the group of patients infected with the RSV phenotype. It is probable that the retrospective nature of the study design, the small sample size and the inclusion of all cases of bacteraemia, irrespective of the source of infection, compromised our ability to draw conclusions about the influence of the RSV phenotype on clinical outcome. Our study also reflects the experience of just a single medical centre and the results might not extrapolate to other hospitals. Nevertheless, it is of interest that we observed significant clonal diversity among MSSA isolates, especially in the RSV group, indicating potential heterogeneity in terms of epidemiology and aetiology.
In summary, our study demonstrated a relationship between the RSV phenotype in MSSA isolates and a lower level of agr expression as measured by RT-PCR. Interestingly, isolates with the agr II genotype showed the lowest level of agr expression. These results may help better understand the role of agr dysfunction in the causal pathway that leads to an increased mortality associated with infections due to these strains. Further studies are needed to determine whether the level of expression of the agr system is a marker of pathogenicity and has an influence on the clinical outcome of MSSA bacteraemia and response to treatment.
